Patents by Inventor Mary Sou

Mary Sou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6770675
    Abstract: An improved ophthalmic composition, including docosanoid active agents, which is especially useful in lowering intraocular pressure associated with glaucoma. Improvements in IOP reduction efficacy, preservative efficacy and reduced additive concentrations are achieved by utilizing the disclosed compositions which include a docosanoid active agent (e.g., isopropyl unoprostone), in conjunction with selected non-ionic surfactants, preservatives, and non-ionic tonicity adjusting agents.
    Type: Grant
    Filed: March 19, 2001
    Date of Patent: August 3, 2004
    Assignee: Novartis AG
    Inventors: Kenneth Warren Reed, Shau Fong Yen, Mary Sou, Regina Flinn Peacock
  • Publication number: 20030031718
    Abstract: Disclosed are a once-a-day ophthalmic drug composition, comprising in particular ketotifen, comprising a polymer comprising chitosan and a carrier, and a method to treat an ocular allergy comprising administering a once-a-day ophthalmic ketotifen composition comprising chitosan to the eye of a mammal.
    Type: Application
    Filed: June 7, 2002
    Publication date: February 13, 2003
    Inventors: Michelle Wong, Mary Sou, Shau-fong Yen, Kasey Minick
  • Publication number: 20020058049
    Abstract: The present invention provides a stable method for storing a pharmaceutical composition containing a prostaglandin-like-compound. The method has the step of storing the composition in a polypropylene container.
    Type: Application
    Filed: September 14, 2001
    Publication date: May 16, 2002
    Inventors: Michelle Pik-Han Wong, Shau-Fong Yen, Mary Sou, Kasey Jon Minick
  • Publication number: 20020002185
    Abstract: An improved ophthalmic composition, including docosanoid active agents, which is especially useful in lowering intraocular pressure associated with glaucoma. Improvements in IOP reduction efficacy, preservative efficacy and reduced additive concentrations are achieved by utilizing the disclosed compositions which include a docosanoid active agent (e.g., isopropyl unoprostone), in conjunction with selected non-ionic surfactants, preservatives, and non-ionic tonicity adjusting agents.
    Type: Application
    Filed: March 19, 2001
    Publication date: January 3, 2002
    Inventors: Kenneth Warren Reed, Shau Fong Yen, Mary Sou, Regina Flinn Peacock
  • Patent number: 5773608
    Abstract: A process for sterilizing a polysaccharide composition containing chitosan, a chitosan derivative or a chitin derivative without substantially degrading the polysaccharide. The process has the steps of blending the polysaccharide in a solvent to form a solution or suspension; sterilizing the solution or suspension; dissolving suspended particles, if present; and then aseptically adjusting the pH of the sterilized solution. There is additionally provided a polyol stabilizing agent suitable for the polysaccharide composition.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: June 30, 1998
    Assignee: CIBA Vision Corporation
    Inventors: Shasy-Fong Yen, Mary Sou